AbbVie Submits Regulatory Applications to FDA and EMA for Upadacitinib (RINVOQ®) for the Treatment of Adults with Moderately to Severely Active Ulcerative ColitisPRNewsWire • 09/16/21
2 Yield Traps To Avoid And 2 High-Yield Aristocrats That Will Make Retirees OverjoyedSeeking Alpha • 09/16/21
AbbVie Inc. (ABBV) CEO Rich Gonzalez Presents at Morgan Stanley Virtual 19th Annual Global Healthcare Conference (Transcript)Seeking Alpha • 09/15/21
AbbVie's deal to develop Regenxbio's investigational gene therapy could be worth $1.8 billionMarket Watch • 09/13/21
AbbVie to Highlight Its Leadership in Movement Disorders at the International Parkinson and Movement Disorder Society Virtual Congress 2021PRNewsWire • 09/10/21
Clinical Trial of Investigational Epcoritamab (DuoBody®-CD3xCD20) in Patients with Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma (B-NHL) Published in The LancetPRNewsWire • 09/09/21
AbbVie to Present Data From Its Migraine Portfolio at the 2021 International Headache CongressPRNewsWire • 09/08/21
Why 5 of the Highest-Yielding Dividend Aristocrats May Be the Safest Bet for Rest of 202124/7 Wall Street • 09/03/21